Stacy Lindborg
Executive VP and Head of Global Clinical Research
Other
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Brainstorm Cell Therapeutics Inc. (BCLI) | Co-Chief Executive Officer Uri Yablonka(\ ), Executive Vice President, Chief Business Officer, Secretary and Director | $475,000 | $1,007,725 |
| 2022 | Brainstorm Cell Therapeutics Inc. (BCLI) | Co-Chief Executive Officer Uri Yablonka(\ ), Executive Vice President, Chief Business Officer, Secretary and Director | $469,000 | $851,543 |
| 2021 | Brainstorm Cell Therapeutics Inc. (BCLI) | Co-Chief Executive Officer | $469,000 | $736,680 |
| 2020 | Brainstorm Cell Therapeutics Inc. (BCLI) | EVP, Chief Development Officer | $218,750 | $867,505 |
Executive changes
Earnings-call appearances
-
Brainstorm Cell Therapeutics Inc. Q3 FY2023 Earnings Call2023-11-14
Brainstorm Cell Therapeutics Inc. (BCLI)
-
Brainstorm Cell Therapeutics Inc. Q2 FY2023 Earnings Call2023-08-14
Brainstorm Cell Therapeutics Inc. (BCLI)
-
Brainstorm Cell Therapeutics Inc. Q1 FY2023 Earnings Call2023-05-15
Brainstorm Cell Therapeutics Inc. (BCLI)
-
Brainstorm Cell Therapeutics Inc. Q4 FY2022 Earnings Call2023-03-30
Brainstorm Cell Therapeutics Inc. (BCLI)
-
Brainstorm Cell Therapeutics Inc. Q3 FY2022 Earnings Call2022-11-14
Brainstorm Cell Therapeutics Inc. (BCLI)
-
Brainstorm Cell Therapeutics Inc. Q2 FY2022 Earnings Call2022-08-15
Brainstorm Cell Therapeutics Inc. (BCLI)
-
Brainstorm Cell Therapeutics Inc. Q1 FY2022 Earnings Call2022-05-16
Brainstorm Cell Therapeutics Inc. (BCLI)
-
Brainstorm Cell Therapeutics Inc. Q4 FY2020 Earnings Call2021-02-04
Brainstorm Cell Therapeutics Inc. (BCLI)
-
Brainstorm Cell Therapeutics Inc. Q3 FY2020 Earnings Call2020-10-15
Brainstorm Cell Therapeutics Inc. (BCLI)